GSK plc (NYSE:GSK) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, a warm welcome to the GSK Full Year 2025 Results Call. I'm delighted to be joined today by Luke Miels, Nina Mojas, Deborah Waterhouse, Tony Wood and Julie Brown.
Glaxosmithkline Plc (GSK)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hourglass Capital Kenneth A. Moffet | 138,409 | $6,787,577 | +6% | 1.46% |
| 2. | Arjuna Capital Farnum Brown And Adam Seitchik | 118,706 | $5,821,343 | -1% | 1.43% |
| 3. | Bailard Inc Thomas Bailard | 17,977 | $881,592 | -6% | 0.02% |
| 4. | Pzena Investment Management Richard S. Pzena | 13,444 | $659,292 | +55% | 0% |
| 5. | Bayforest Capital Theodoros Tsagaris | 8,204 | $402,324 | -9% | 0.3% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,280,883 | $308,014,503 | 0.05% | |
| 2. | 1,650,304 | $81,359,987 | 1.06% | |
| 3. | 1,642,114 | $80,529,271 | 2.43% | |
| 4. | 1,044,790 | $51,236,508 | 0.7% | |
| 5. | 890,098 | $43,650,406 | 2.71% |
News See All
Jefferies Reaffirms a Buy Rating on GSK plc (GSK) - Here's Why
GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc (NYSE:GSK) on January 7 and set a price target of $55.60.
10 Best Performing Pharma Stocks in 2025
On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his bullish outlook on biopharma stocks in 2026 and the pharma M&A outlook...
Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now?
GSK plc (NYSE:GSK) is one of the best affordable healthcare stocks to buy now.
10 Best Affordable Healthcare Stocks to Buy Now
According to him, this has been a year where certain areas of healthcare, particularly those related to health spend or real significant turnarounds in business, have performed pretty well, allowing certain...
HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target
On December 10, HSBC analyst Rajesh Kumar raised the firm’s price target on GSK plc (NYSE:GSK) to 1,500 GBp from 1,200 GBp and kept a Reduce rating on the shares.
15 Global Dividend Stocks to Diversify Your Portfolio
Dividend stocks are back in focus, and not just in the US, but investors around the world are leaning into income again, and the data shows why.
GSK (GSK) Scores Win in the Form of Lung Cancer Drug's Orphan Drug Designation
GSK plc (NYSE:GSK) is one of the largest pharmaceutical companies in the world.
13 Best ADR Stocks to Invest In
ADRs, or American Depository Receipts, are the US-listed securities of foreign firms that allow investors in America to buy and trade the shares within America.
J.P. Morgan Maintains a Sell Rating on GSK plc (GSK)
In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the initiation of litigation against AnaptysBio, Inc.
Hedge Fund Resource Center Billionaire Hedge Funds
